{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:09:45Z","timestamp":1788772185276,"version":"build-2803163510"},"reference-count":44,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.25122\/jml-2026-0012","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:34:15Z","timestamp":1788770055000},"page":"359-365","source":"Crossref","is-referenced-by-count":0,"title":["Effects of combined metformin and cabergoline versus metformin alone on inflammatory markers in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial"],"prefix":"10.25122","volume":"19","author":[{"given":"Inas Naser","family":"Hamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Maternity and Pediatric Teaching Hospital, Al Diwaniyah, Iraq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinaa Abdul Amir","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology, College of Medicine, University of Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology, College of Medicine, University of Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swadi","family":"Asma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology, College of Medicine, University of Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi Hayder","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacy, Al-Mustafa University College, Baghdad, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","reference":[{"issue":"8","key":"ref1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls","volume":"3","author":"Witchel SF, Oberfield SE, Pe\u00f1a AS","year":"2019","unstructured":"1. Witchel SF, Oberfield SE, Pe\u00f1a AS, Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls, J Endocr Soc, 2019;3(8):1545-1573","journal-title":"J Endocr Soc"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","article-title":"Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing","volume":"23","author":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M","year":"2022","unstructured":"2. Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing, Int J Mol Sci, 2022;23(2):583","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ref3","first-page":"336","article-title":"Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches","volume":"38","author":"Ndefo UA, Eaton A, Green MR","year":"2013","unstructured":"3. Ndefo UA, Eaton A, Green MR, Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches, P T, 2013;38(6):336-55","journal-title":"P T"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/GRF.0b013e3182353c98","article-title":"Polycystic ovary syndrome: current infertility management","volume":"54","author":"Aubuchon M, Legro RS","year":"2011","unstructured":"4. Aubuchon M, Legro RS, Polycystic ovary syndrome: current infertility management, Clin Obstet Gynecol, 2011;54(4):675-84","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"108: Polycystic ovary syndrome","volume":"114","author":"ACOG Practice Bulletin No","year":"2009","unstructured":"5. ACOG Practice Bulletin No, 108: Polycystic ovary syndrome, Obstet Gynecol, 2009;114(4):936","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/dhps.s4388","article-title":"Polycystic ovary syndrome and its impact on women\u2019s quality of life: More than just an endocrine disorder","volume":"1","author":"Brady C, Mousa SS, Mousa SA","year":"2009","unstructured":"6. Brady C, Mousa SS, Mousa SA, Polycystic ovary syndrome and its impact on women\u2019s quality of life: More than just an endocrine disorder, Drug Healthc Patient Saf, 2009;19-15","journal-title":"Drug Healthc Patient Saf"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","article-title":"The role of low-grade inflammation in the polycystic ovary syndrome","volume":"335","author":"Repaci A, Gambineri A, Pasquali R","year":"2011","unstructured":"7. Repaci A, Gambineri A, Pasquali R, The role of low-grade inflammation in the polycystic ovary syndrome, Mol Cell Endocrinol, 2011;335(1):30-41","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"ref8","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou E, Vrachnis N, Athanasopoulos N, Iliodromiti Z, Sifakis S, Iliodromiti S","year":"2012","unstructured":"8. Deligeoroglou E, Vrachnis N, Athanasopoulos N, Iliodromiti Z, Sifakis S, Iliodromiti S, Mediators of chronic inflammation in polycystic ovarian syndrome, Gynecol Endocrinol, 2012;28(12):974-8","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"ref9","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/ijms22052734","article-title":"The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis","volume":"22","author":"Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE, Amer S","year":"2021","unstructured":"9. Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE, Amer S, The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis, Int J Mol Sci, 2021;22(5):2734","journal-title":"Int J Mol Sci"},{"issue":"3-4","key":"ref10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","article-title":"Inflammatory mechanisms in the regulation of insulin resistance","volume":"14","author":"Tilg H, Moschen AR","year":"2008","unstructured":"10. Tilg H, Moschen AR, Inflammatory mechanisms in the regulation of insulin resistance, Mol Med, 2008;14(3-4):222-31","journal-title":"Mol Med"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","article-title":"Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors","volume":"93","author":"Kaya C, Pabuccu R, Berker B, Satiroglu H","year":"2010","unstructured":"11. Kaya C, Pabuccu R, Berker B, Satiroglu H, Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors, Fertil Steril, 2010;93(4):1200-7","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"389317","DOI":"10.1155\/2011\/389317","article-title":"IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance","volume":"2011","author":"Fulghesu AM, Sanna F, Uda S, Magnini R, Portoghese E, Batetta B","year":"2011","unstructured":"12. Fulghesu AM, Sanna F, Uda S, Magnini R, Portoghese E, Batetta B, IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance, Mediators Inflamm, 2011;2011389317","journal-title":"Mediators Inflamm"},{"issue":"4","key":"ref13","first-page":"323","article-title":"Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome","volume":"15","author":"Makedos A, Goulis DG, Arvanitidou M, Mintziori G, Papanikolaou A, Makedou A","year":"2011","unstructured":"13. Makedos A, Goulis DG, Arvanitidou M, Mintziori G, Papanikolaou A, Makedou A, Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome, Hippokratia, 2011;15(4):323-6","journal-title":"Hippokratia"},{"issue":"2","key":"ref14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.14310\/horm.2002.1584","article-title":"Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors","volume":"14","author":"Barcellos CR, Rocha MP, Hayashida SA, Dantas WS, Dos Reis Vieira Yance V, Marcondes JA","year":"2015","unstructured":"14. Barcellos CR, Rocha MP, Hayashida SA, Dantas WS, Dos Reis Vieira Yance V, Marcondes JA, Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors, Hormones (Athens), 2015;14(2):251-7","journal-title":"Hormones (Athens)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jclinepi.2019.03.014","article-title":"A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions","volume":"113","author":"Bennett WL, Aschmann HE, Puhan MA, Robbins CW, Bayliss EA, Wilson R","year":"2019","unstructured":"15. Bennett WL, Aschmann HE, Puhan MA, Robbins CW, Bayliss EA, Wilson R, A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions, J Clin Epidemiol, 2019;11392-100","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jcem.85.1.6293","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M","year":"2000","unstructured":"16. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation, J Clin Endocrinol Metab, 2000;85(1):139-46","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"ref17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F","year":"2012","unstructured":"17. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F, Cellular and molecular mechanisms of metformin: an overview, Clin Sci (Lond), 2012;122(6):253-70","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"ref18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1463-1326.2004.00448.x","article-title":"Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents","volume":"7","author":"Goodarzi MO, Bryer-Ash M","year":"2005","unstructured":"18. Goodarzi MO, Bryer-Ash M, Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents, Diabetes Obes Metab, 2005;7(6):654-65","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"ref19","first-page":"93","article-title":"Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia","volume":"13","author":"Ghaneei A, Jowkar A, Hasani Ghavam MR, Ghaneei ME","year":"2015","unstructured":"19. Ghaneei A, Jowkar A, Hasani Ghavam MR, Ghaneei ME, Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia, Iran J Reprod Med, 2015;13(2):93-100","journal-title":"Iran J Reprod Med"},{"issue":"1","key":"ref20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12020-012-9857-y","article-title":"Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma","volume":"44","author":"Inancli SS, Usluogullari A, Ustu Y, Caner S, Tam AA, Ersoy R","year":"2013","unstructured":"20. Inancli SS, Usluogullari A, Ustu Y, Caner S, Tam AA, Ersoy R, Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma, Endocrine, 2013;44(1):193-9","journal-title":"Endocrine"},{"issue":"3","key":"ref21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/path.1642","article-title":"Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients","volume":"204","author":"Bei R, Budillon A, Masuelli L, Cereda V, Vitolo D, Di Gennaro E","year":"2004","unstructured":"21. Bei R, Budillon A, Masuelli L, Cereda V, Vitolo D, Di Gennaro E, Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients, J Pathol, 2004;204(3):317-25","journal-title":"J Pathol"},{"issue":"4","key":"ref22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review","volume":"13","author":"Deswal R, Narwal V, Dang A, Pundir CS","year":"2020","unstructured":"22. Deswal R, Narwal V, Dang A, Pundir CS, The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review, J Hum Reprod Sci, 2020;13(4):261-271","journal-title":"J Hum Reprod Sci"},{"key":"ref23","article-title":"Biostatistics: a foundation for analysis in the health sciences: Wiley","author":"Daniel WW, Cross CL","year":"2018","unstructured":"23. Daniel WW, Cross CL, Biostatistics: a foundation for analysis in the health sciences: Wiley, 2018;"},{"issue":"3","key":"ref24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body Mass Index: Obesity, BMI, and Health: A Critical Review","volume":"50","author":"Nuttall FQ","year":"2015","unstructured":"24. Nuttall FQ, Body Mass Index: Obesity, BMI, and Health: A Critical Review, Nutr Today, 2015;50(3):117-128","journal-title":"Nutr Today"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7827-9-7","article-title":"Is interleukin-18 associated with polycystic ovary syndrome?","volume":"9","author":"Yang Y, Qiao J, Li R, Li MZ","year":"2011","unstructured":"25. Yang Y, Qiao J, Li R, Li MZ, Is interleukin-18 associated with polycystic ovary syndrome?, Reprod Biol Endocrinol, 2011;97","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"ref26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1210\/jc.2003-031365","article-title":"Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity","volume":"89","author":"Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Mill\u00e1n JL","year":"2004","unstructured":"26. Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Mill\u00e1n JL, Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity, J Clin Endocrinol Metab, 2004;89(2):806-11","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1385\/ENDO:29:3:419","article-title":"Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome","volume":"29","author":"Zhang YF, Yang YS, Hong J, Gu WQ, Shen CF, Xu M","year":"2006","unstructured":"27. Zhang YF, Yang YS, Hong J, Gu WQ, Shen CF, Xu M, Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome, Endocrine, 2006;29(3):419-23","journal-title":"Endocrine"},{"issue":"4","key":"ref28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/09513590.2017.1395835","article-title":"The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome","volume":"34","author":"Dawood A, Alkafrawy N, Saleh S, Noreldin R, Zewain S","year":"2018","unstructured":"28. Dawood A, Alkafrawy N, Saleh S, Noreldin R, Zewain S, The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome, Gynecol Endocrinol, 2018;34(4):294-297","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"ref29","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F","year":"2011","unstructured":"29. Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F, Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis, Fertil Steril, 2011;95(3):1048-58.e12","journal-title":"Fertil Steril"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/09513590.2016.1203893","article-title":"Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries","volume":"33","author":"Elci E, Kaya C, Cim N, Yildizhan R, Elci GG","year":"2017","unstructured":"30. Elci E, Kaya C, Cim N, Yildizhan R, Elci GG, Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries, Gynecol Endocrinol, 2017;33(1):43-47","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"ref31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.20945\/2359-3997000000197","article-title":"Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin","volume":"64","author":"Cardoso NS, Ribeiro VB, Dutra SGV, Ferriani RA, Gastaldi AC, Ara\u00fajo JE, Souza HCD","year":"2020","unstructured":"31. Cardoso NS, Ribeiro VB, Dutra SGV, Ferriani RA, Gastaldi AC, Ara\u00fajo JE, Souza HCD, Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin, Arch Endocrinol Metab, 2020;64(1):4-10","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","article-title":"Is PCOS an inflammatory process?","volume":"97","author":"Duleba AJ, Dokras A","year":"2012","unstructured":"32. Duleba AJ, Dokras A, Is PCOS an inflammatory process?, Fertil Steril, 2012;97(1):7-12","journal-title":"Fertil Steril"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"A324","DOI":"10.1210\/jendso\/bvac150.671","article-title":"ODP220 Latent autoimmune diabetes of adults and PCOS: an unusual combination","volume":"6","author":"Pisklakova A, Nagrani M, Mohanachandran S, Abraham J","year":"2022","unstructured":"33. Pisklakova A, Nagrani M, Mohanachandran S, Abraham J, ODP220 Latent autoimmune diabetes of adults and PCOS: an unusual combination, J Endocr Soc, 2022;6(Suppl 1):A324","journal-title":"J Endocr Soc"},{"key":"ref34","article-title":"Detection of type 2 diabetes mellitus in serum from women with polycystic ovarian syndrome","volume":"10","author":"Saadi R, Salloom D, Abbas A","year":"2013","unstructured":"34. Saadi R, Salloom D, Abbas A, Detection of type 2 diabetes mellitus in serum from women with polycystic ovarian syndrome, Iraqi J Sci, 2013;10","journal-title":"Iraqi J Sci"},{"issue":"12","key":"ref35","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1007\/s10072-020-04466-7","article-title":"Glutamic acid decarboxylase antibodies in neurocritical patients: a culprit or a bystander?","volume":"41","author":"Wang D, Huang K, Lin Z, Zhang Y, Liu G, Wu Y","year":"2020","unstructured":"35. Wang D, Huang K, Lin Z, Zhang Y, Liu G, Wu Y, Glutamic acid decarboxylase antibodies in neurocritical patients: a culprit or a bystander?, Neurol Sci, 2020;41(12):3691-3696","journal-title":"Neurol Sci"},{"issue":"2","key":"ref36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1507\/endocrj.EJ15-0548","article-title":"A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin","volume":"63","author":"Shigiyama F, Kumashiro N, Rikitake T, Usui S, Saegusa M, Kitamura M","year":"2016","unstructured":"36. Shigiyama F, Kumashiro N, Rikitake T, Usui S, Saegusa M, Kitamura M, A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin, Endocr J, 2016;63(2):193-8","journal-title":"Endocr J"},{"issue":"8","key":"ref37","doi-asserted-by":"publisher","first-page":"bvaa078","DOI":"10.1210\/jendso\/bvaa078","article-title":"The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome","volume":"4","author":"Kem DC, Li H, Yu X, Weedin E, Reynolds AC, Forsythe E","year":"2020","unstructured":"37. Kem DC, Li H, Yu X, Weedin E, Reynolds AC, Forsythe E, The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome, J Endocr Soc, 2020;4(8):bvaa078","journal-title":"J Endocr Soc"},{"issue":"4","key":"ref38","doi-asserted-by":"publisher","first-page":"e0249639","DOI":"10.1371\/journal.pone.0249639","article-title":"Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome","volume":"16","author":"Sattler LM, Schniewind HA, Minich WB, Haudum CW, Niklowitz P, M\u00fcnzker J","year":"2021","unstructured":"38. Sattler LM, Schniewind HA, Minich WB, Haudum CW, Niklowitz P, M\u00fcnzker J, Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome, PLoS One, 2021;16(4):e0249639","journal-title":"PLoS One"},{"issue":"1","key":"ref39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.20945\/2359-3997000000442","article-title":"Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome","volume":"66","author":"Kabakchieva P, Gateva A, Velikova T, Georgiev T, Yamanishi K, Okamura H","year":"2022","unstructured":"39. Kabakchieva P, Gateva A, Velikova T, Georgiev T, Yamanishi K, Okamura H, Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome, Arch Endocrinol Metab, 2022;66(1):3-11","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"ref40","first-page":"1989","article-title":"Serum level evaluation of interleukin-18 in obese women with polycystic ovary syndrome","volume":"59","author":"Ibrahim MII, Al-Saffar JM","year":"2018","unstructured":"40. Ibrahim MII, Al-Saffar JM, Serum level evaluation of interleukin-18 in obese women with polycystic ovary syndrome, Iraqi J Sci, 2018;59(4):1989-1994","journal-title":"Iraqi J Sci"},{"issue":"4","key":"ref41","first-page":"1653","article-title":"Changes in IL-18 level in response to metformin treatment in Iraqi women with poly cystic ovarian syndrome: placebo controlled study","volume":"6","author":"Al-Qadhi HI, Al-Tai THH, Hussein SY","year":"2017","unstructured":"41. Al-Qadhi HI, Al-Tai THH, Hussein SY, Changes in IL-18 level in response to metformin treatment in Iraqi women with poly cystic ovarian syndrome: placebo controlled study, Int J Sci Res, 2017;6(4):1653-1656","journal-title":"Int J Sci Res"},{"issue":"3","key":"ref42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.31482\/mmsl.2021.039","article-title":"Metformin may ameliorate inflammatory events of IL-18 in some inflammatory conditions","volume":"91","author":"Alzamily AA, Obaid KM, Al-Azzawi B","year":"2022","unstructured":"42. Alzamily AA, Obaid KM, Al-Azzawi B, Metformin may ameliorate inflammatory events of IL-18 in some inflammatory conditions, Mil Med Sci Lett, 2022;91(3):170-181","journal-title":"Mil Med Sci Lett"},{"issue":"9","key":"ref43","article-title":"Effect of metformin therapy on serum interleukin-6 and interleukin-18 levels in patients with polycystic ovary syndrome","volume":"8","author":"ElMekkawi SF, ElHosseiny AS, Mansour GM, Abbas AA, Asaad AM, Ali KS","year":"2010","unstructured":"43. ElMekkawi SF, ElHosseiny AS, Mansour GM, Abbas AA, Asaad AM, Ali KS, Effect of metformin therapy on serum interleukin-6 and interleukin-18 levels in patients with polycystic ovary syndrome, Nat Sci, 2010;8(9):","journal-title":"Nat Sci"},{"issue":"3","key":"ref44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1871530315666150316124019","article-title":"Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect","volume":"15","author":"Saisho Y","year":"2015","unstructured":"44. Saisho Y, Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect, Endocr Metab Immune Disord Drug Targets, 2015;15(3):196-205","journal-title":"Endocr Metab Immune Disord Drug Targets"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-5-2026\/original-article-issue-5-2026\/effects-of-combined-metformin-and-cabergoline-versus-metformin-alone-on-inflammatory-markers-in-iraqi-patients-with-pcos-and-hyperprolactinemia-a-randomized-clinical-trial\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:34:25Z","timestamp":1788770065000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-5-2026\/original-article-issue-5-2026\/effects-of-combined-metformin-and-cabergoline-versus-metformin-alone-on-inflammatory-markers-in-iraqi-patients-with-pcos-and-hyperprolactinemia-a-randomized-clinical-trial\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["JMedLife-19-359"],"URL":"https:\/\/doi.org\/10.25122\/jml-2026-0012","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}